FDA — authorised 12 October 1993
- Application: NDA019762
- Marketing authorisation holder: ALZA
- Local brand name: TESTODERM
- Indication: FILM, EXTENDED RELEASE — TRANSDERMAL
- Status: approved
FDA authorised therapeutic testosterone on 12 October 1993
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. FDA authorised it on 12 October 1993.
ALZA holds the US marketing authorisation.